Sachem Head Capital Management’s CVS Health CVS Stock Holding History

Sachem Head Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,585,000	Closed	-$205M	–	21
2025 Q4	$205M	Sell	2,585,000 -565,000	-18%	-$44.5M	4.81%	12
2025 Q3	$237M	Buy	3,150,000 +130,000	+4%	+$8.91M	6.71%	6
2025 Q2	$208M	Sell	3,020,000 -110,000	-4%	-$7.21M	6.5%	6
2025 Q1	$212M	Buy	3,130,000 +2,505,000	+401%	+$150M	8.5%	3
2024 Q4	$28.1M	Sell	625,000 -2,895,000	-82%	-$162M	1.55%	14
2024 Q3	$221M	Buy	3,520,000 +1,070,000	+44%	+$62.4M	11.61%	2
2024 Q2	$145M	Buy	+2,450,000	New	+$153M	7.19%	4

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sachem Head Capital Management's CVS Position: Q1 2026 in Review

Sachem Head Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,585,000 shares — an estimated $205M sold.

Sachem Head Capital Management first reported a position in CVS in Q2 2024 and held it in 7 quarters. The position peaked at $237M in Q3 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Sachem Head Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Sachem Head Capital Management sold 2,585,000 CVS Health shares in Q1 2026, an estimated $205M.
Sachem Head Capital Management first reported a position in CVS Health in Q2 2024 and held it in 7 quarters.
Sachem Head Capital Management's CVS Health position peaked at $237M in Q3 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Sachem Head Capital Management's 13F filing for Q1 2026, filed 15 May 2026.